Likewise, other agonists of GPER also showed satisfactory results in inhibiting cell proliferation and disrupting the cell cycle in PC.191 Together, these results indicate that GPER is a promising therapeutic target in the estrogen-related treatment of PC. The gene discussed is GPER1; the disease is pachyonychia congenita.